Background and objective: Diffusion-weighted imaging has an emerging role for assessment of focal and diffuse liver diseases. The aim of this study was to evaluate the diagnostic performance of DWI for characterization of focal liver lesions (FLLs). Patients and methods: This prospective study included 40 consecutive patients with 64 focal liver lesions, who underwent MRI of the liver. All patients had one or more hepatic focal lesion of diameter more than 1 cm. DWI was reviewed (b values of 0, 50 and 600 s/mm 2 ) and the mean ADC was calculated.
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Background and objective: Diffusion-weighted imaging has an emerging role for assessment of focal and diffuse liver diseases. The aim of this study was to evaluate the diagnostic performance of DWI for characterization of focal liver lesions (FLLs). Patients and methods: This prospective study included 40 consecutive patients with 64 focal liver lesions, who underwent MRI of the liver. All patients had one or more hepatic focal lesion of diameter more than 1 cm. DWI was reviewed (b values of 0, 50 and 600 s/mm 2 ) and the mean ADC was calculated.
Results: Quantitative assessment using ADC map was more accurate (87.5%) than qualitative assessment using DWI ( 
Introduction
Focal liver lesions (FLLs) are common in the general population. FLLs could be classified into 3 clinical categories: first, benign lesions for which no treatment is needed (hepatic hemangioma, focal nodular hyperplasia (FNH), benign liver cyst, and focal fat sparing); second, benign lesions for which treatment is required (hepatic adenoma, adenomatosis, biliary cystadenoma, hepatic abscess, echinococcal cyst, granulomatous inflammation and inflammatory psuedotumor of the liver); and third, malignant mass lesions for which treatment is always required if feasible (hepatocellular carcinoma (HCC), cholangiocarcinoma, liver metastases from other primary sites, biliary cystadenocarcinoma, hepatic angiosarcoma and lymphoma) [1] .
Differentiation between malignant and benign FLLs and establishing the correct diagnosis are of great importance in treatment planning for patients with liver neoplasms and in patients without neoplasms for avoiding unnecessary liver biopsies.
Imaging is an important decision-making tool in the diagnosis of FLLs as it can accurately differentiate benign from malignant lesions in most of the cases [2] . Ultrasound (US), computed tomography (CT) and magnetic resonance imaging (MRI) are the common modalities used. A metaanalysis study comparing contrast-enhanced ultrasound, CT, and MRI in evaluating incidental FLLs showed nearly similar diagnostic performance with specificities ranging from 82% to 89% without significant difference in the summary receiver operating characteristic curve (ROC) [3] . Because of the ionizing radiation of CT and relative nonavailability of ultrasound contrast, MRI is considered the imaging modality of choice for FLL characterization. It relies on the signal characteristics of T1-weighted, T2-weighted, and dynamic gadolinium-enhanced T1-weighted imaging [4] [5] [6] .
Diffusion weighted imaging (DWI) is a relatively recent imaging tool, which enables qualitative and quantitative assessment of tissue diffusivity without use of contrast agent.
The sensitivity of a DWI sequence is characterized by its b-value, which reflects the influence of the gradients in DWI. The higher the b-value, the more sensitive the sequence is to diffusion effects. DWI is performed with at least two b-values. Diffusion is quantitatively expressed in the apparent diffusion coefficient (ADC) which is related to the molecular mobility of water molecules and reflects tissue properties such as the size of the extracellular space, viscosity and cellularity. Low ADC values reflect restricted diffusion, and thus in highly cellular tissues. High ADC values denote areas with relative free diffusion, and thus in low cellular tissues [7, 8] .
With advances in hardware and coil systems, DWI has a high contrast resolution allowing accurate FLLs detection and characterization [9] . There are an increasing number of studies concerned about quantitative measurements of apparent diffusion coefficient (ADC) in liver lesions; however, many discrepancies were founded in the reported ADC values [10] . Thus, the purpose of this study was to evaluate the qualitative and quantitative diagnostic performance of DWI for characterization of FLLs and to reach the best ADC cutoff for distinction between malignant and benign lesions.
Patients and methods
This study included 40 non-consecutive patients, 26 males and 14 females, ranging in age from 20-to 85 years old (mean, 58 years), who underwent MR imaging of the liver in MRI unit in Diagnostic Radiology Department at Sohag University Hospital from April 2012 to April 2013. The inclusion criteria were Adult patients who had one or more FLLs with a diameter more than 1 cm. Exclusion criteria were as follows: patients under age of 18 years, patients had no FLLs or had FLLs with a diameter less than 1 cm or had previously treated lesions. Patients who did not undergo DWI nor had non-interpretable DWI sequences due to artifacts were also excluded.
Written consent was taken from the patients in accord with the ethics committee of our institution. tion. The ADC value of each FLL was calculated within a region of interest (ROI) placed in the center of the assessed lesion, covering more than 50% of its surface. In cases of necrotic FLLs, measurements were taken only in the solid part, trying to avoid inclusion within the ROI of any necrotic part. Each lesion was individually analyzed in cases with multiple FLLs. Mean ADC measurement was calculated for each hepatic pathology.
Image analysis
The following data were recorded for each FLL: site, size, morphology, signal intensity of all used sequences (dynamic contrast material-enhanced T1WI, T2W FSE, STIR, DWI and ADC map).
The lesion was considered benign if it was hyperintense on DW images at b = 0 s/mm 2 and strongly decreased in signal intensity at b = 600 s/mm 2 and subjectively higher an ADC than that of the liver, apart from regeneration nodules (9 cases), those had low signal in T2WIs and hence low signal at b = 0, and b = 600, while the lesion was considered malignant if it was mildly to moderately hyperintense on DW images at b = 0 s/mm 2 and remained hyperintense at b = 600 s/mm 2 compared with liver parenchyma, with ADC signal lower than that of the liver parenchyma. If the above criteria were not obtained (e.g. isointense ADC or there was a partial signal intensity decrease), the lesion was considered indeterminate [11] [12] [13] . Our standard of reference was based on the histopathological findings in 21 patients (9 HCCs, 5 metastatic lesions, 3 cholangiocarcinomas, 2 liver abscesses, one intra hepatic hematoma, and one FNH). Diagnosis of the remaining 19 cases was based on clinical data, typical MR imaging findings (T2-weighted, and dynamic contrast material-enhanced T1-weighted images), findings of other imaging modalities (CT and U/S), and clinical and imaging followup results.
Statistical analysis
Descriptive analyses of demographic, clinical, radiological, and pathological characteristics were done. The variables studied were described with mean ± standard deviation to measure the degree of dispersion of data around their mean. T-student test was applied to test the presence of significant differences between two comparable qualitative variables (benign versus malignant), depending on the features assessed. The receiver operating characteristic curve was constructed and its parameters (sensitivity, specificity, positive predictive value, and negative predictive value) as well as the accuracy for each ADC threshold were estimated to identify the best ADC value to distinguish between benign and malignant FLLs.
SPSS statistical software was used with P value less than 0.05 was considered to indicate a significant difference.
Results
A total of 40 consecutive adult patients had 64 HFLs with an average diameter of 3.4 cm (range from 1.2 to 14 cm) met all of the inclusion criteria, 26 males (65%) and 14 females (35%), ranging in age from 20 to 85 years old (mean, 58 years). Twenty-four patients (60%) presented with 36 malignant liver lesions; 20 metastases, 13 hepatocellular carcinomas (Fig. 1 ) and 3 Cholangiocarcinomas ( Fig. 2 ) and sixteen patients (40%) presented with 28 benign liver lesions; 12 hemangiomas (Fig. 3) , 9 regenerating nodules, 3 cysts (Fig. 4), 2 abscesses (Fig. 5 ), 1 focal nodular hyperplasia (Fig. 6 ) and 1 hematoma. The average number of FLLs/patient was 1.6. None of the patients simultaneously had benign and malignant liver lesions.
12 patients had a history of chronic liver disease (5 chronic hepatitis and 7 liver cirrhosis) and 6 patients had history of primary malignancy (2 cancer breast, 2 renal cell carcinoma, one cancer bladder (Fig. 7) and one lymphoma (Fig. 8) . The remaining 22 patients, who had no history of malignancy or chronic liver disease, underwent MR imaging for further evaluation of FLLs diagnosed by CT and or US.
Analysis of signal intensity on the b-600 showed statistically significant difference between benign and malignant FLLs (p value <0.001) with sensitivity and specificity of hyperintensity for malignant FLLs were 91.7% and 53.5% respectively while decreased hyperintensity showed sensitivity and specificity for benign FLLs of 83.3% and 71.1% respectively. The overall accuracy of qualitative DW images for FLLs characterization was 75% (48 of 64) Table 1 .
Analysis of signal intensity on the ADC map showed that hypointensity on ADC map is 100% specific for malignant FLLs diagnosis. On the other hand specificity of hyperintensity on the ADC map for benign FLLs was 97.2%. The overall accuracy of ADC map in FLLs characterization was 87.5% Table 2 . Mean ADC values of all included FLLs were reflected in Table 3 . Mean ADC values of malignant lesions (0.94 ± 0.32 Â 10 À3 mm 2 /s) were significantly lower than those of benign lesions (2.64 ± 0.46 Â 10 À3 mm 2 /s) with a significant overlap (Fig. 9) . Using 1.05 as a cutoff ADC value led to a sensitivity for malignancy of 63.9% and specificity of 96.4% with 78.1% accuracy. Using a higher ADC value, such as 1.6, the sensitivity and specificity for malignancy were 100% and 67.9% respectively with 86% accuracy and 100% negative predictive value Table 4 .
Discussion
Most of liver masses arising in noncirrhotic livers are benign. The most common solid benign lesions are hemangiomas, adenomas, and FNH [14, 15] , while metastases are the most commonly encountered malignant lesions [3] . HCC and intrahepatic cholangiocarcinoma occur in the setting of chronic liver disease [16] .
In most cases, the differential diagnosis of FLLs is straightforward, as the majority of FLLs have a characteristic imaging aspect allowing a confident final diagnosis; however, imaging diagnosis of atypical FLL is difficult, and follow-up and/or biopsy are often required [2] .
MRI is the imaging test of choice for liver-mass characterization, demonstrating similar if not superior performance to CT. DWI plays an emerging role for the assessment of focal and diffuse liver diseases. DWI can be easily included in routine liver MRI protocols, as it takes a short time as two breathhold acquisitions and noncontrast technique; so, it can be done for patients with severe renal insufficiency, at risk for nephrogenic systemic fibrosis [9] . DWI is a measure of the ability of water molecule protons to diffuse freely within intra-and extracellular environments. Therefore, DWI of FLL denotes cellular density of the lesion, while ADC values are quantifiable measures reflecting both diffusion and perfusion within imaged tissue [16] .
In the present study, qualitative (signal intensity on DW images and ADC map) and quantitative (ADC value) were used to differentiate between benign and malignant FLLs. In accordance with the previous literature [11] [12] [13] , we used b value of 0, 50 and 600 s/mm 2 for visual discrimination between benign and malignant FLLs, on the basis of lesion morphology, signal intensity and degree of signal intensity decrease with increasing b values, and it showed 75% overall accuracy for FLLs characterization compared with 89.1% reported by Parikh et al. in their study [17] . The lower percentage of our results could be a result of the common pitfalls of DWI including slow-flowing blood in hemangioma that is responsible for its high signal intensity on b value 600 and consequently it could be mistaken for malignant lesion [18] , and T2 shine-through phenomenon that was encountered in 11 (39.3%) benign FLLs on b value 600.
T2 shine-through phenomenon describes a lesion that shows restricted diffusion on DWI because of the long T2-relaxation time rather than the limited mobility of the water protons. The presence of T2 shine-through is known by correlation of high-b -value images with the ADC map. Areas demonstrating mainly T2 shine-through rather than restricted diffusion have high diffusivity on the ADC map and high ADC values [19] , as it was confirmed in our results with increased overall accuracy for FLLs characterization on ADC map up to 87.5%. Therefore, DW images should be interpreted in combination with the ADC map and conventional MRI sequences to avoid misinterpretation.
Several studies have been suggested that ADC values can discriminate between benign and malignant focal liver lesions [20] [21] [22] [23] [24] [25] , but many discrepancies in the reported ADC values were encountered. This is mainly because of using different techniques, scanning parameters and different b-values [21] , in addition to the different liver lesions assessed.
In accordance with the more performed techniques in previous studies, 0, 50 and 600 s/mm 2 b values were used in the present study to calculate the ADC values and images were obtained using triggered breathing. In general, malignant FLLs have ADC values lower than those of benign lesions, with overlap of variable degrees [19] . Lower ADC values for most malignant lesions are thought to be due to cellular membranes impeding the water molecules mobility. However, solid benign lesions with high cellularity also have low ADC values. On the other hand, cystic and necrotic malignant lesions exhibit high ADC values as a result of larger diffusion distances caused by lost membrane integrity [21] .
In the current study, Mean ADC values of malignant lesions (0.94 ± 0.32 Â 10 À3 mm 2 /s) were significantly /s) with overlap in-between. As the most challenging task in FLLs diagnosis is to differentiate between malignant and benign solid liver tumors, detection of the best ADC cutoff value and its accuracy to distinguish malignant and solid benign liver lesions are valuable.
Different ADC cutoffs (1.4-1.6 Â 10 À3 mm 2 /s) have been reported in previous studies, with a sensitivity ranged from 74% to 100% and specificity ranged from 77% to 100% for diagnosing malignant lesions [11, 17, 20, [26] [27] [28] . However, the specificity decreased by exclusion of cysts and hemangiomas, suggesting that the ADC cutoff is not as effective in differentiation of malignant lesions from FNHs, adenomas, or abscesses.
Our results reported accuracy of ADC cutoff for the diagnosis of malignant focal lesions, ranged from 78.1% to 86% depending on ADC threshold used. Using ADC cutoff of By comparing our ADC cutoff with the literature, differences in sensitivity and specificity and accuracy are small. The only study with significantly different results from ours included 38 patients presented with 37 FLLs and 68% of the benign lesions were biliary cysts with significantly higher ADC value than other lesions [20] .
Some potential limitations are encountered in this study; first is the limited image quality of single shot SE echo-planar DW MR imaging, including low spatial resolution, poor SNR, and echo-planar imaging-related artifacts. Second, the small number of patients relative to the high 
Conclusion
DWI is a useful tool for FLLs characterization. Qualitative DWI assessment is not sufficient alone and should be combined with quantitative ADC value calculation. DWI should be included in routine liver MR protocols, however, because of its known pitfalls and limitations, mainly the substantial overlap in the range of ADCs between solid benign and malignant lesions, it should be interpreted in combination with clinical history and conventional sequences including contrast enhanced MRI.
